HUE049460T2 - Heterociklusos vegyület és annak alkalmazása ampa receptor pozitív allosztérikus modulátorként - Google Patents

Heterociklusos vegyület és annak alkalmazása ampa receptor pozitív allosztérikus modulátorként

Info

Publication number
HUE049460T2
HUE049460T2 HUE11749944A HUE11749944A HUE049460T2 HU E049460 T2 HUE049460 T2 HU E049460T2 HU E11749944 A HUE11749944 A HU E11749944A HU E11749944 A HUE11749944 A HU E11749944A HU E049460 T2 HUE049460 T2 HU E049460T2
Authority
HU
Hungary
Prior art keywords
heterocyclic compound
positive allosteric
receptor positive
ampa receptor
allosteric modulator
Prior art date
Application number
HUE11749944A
Other languages
English (en)
Hungarian (hu)
Inventor
Masakuni Kori
Toshihiro Imaeda
Shinji Nakamura
Masashi Toyofuku
Eiji Honda
Yasutomi Asano
Osamu Ujikawa
Michiyo Mochizuki
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of HUE049460T2 publication Critical patent/HUE049460T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
HUE11749944A 2010-08-10 2011-08-09 Heterociklusos vegyület és annak alkalmazása ampa receptor pozitív allosztérikus modulátorként HUE049460T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010179577 2010-08-10

Publications (1)

Publication Number Publication Date
HUE049460T2 true HUE049460T2 (hu) 2020-09-28

Family

ID=44534564

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE11749944A HUE049460T2 (hu) 2010-08-10 2011-08-09 Heterociklusos vegyület és annak alkalmazása ampa receptor pozitív allosztérikus modulátorként

Country Status (39)

Country Link
US (11) US8575154B2 (https=)
EP (1) EP2603513B1 (https=)
JP (2) JP5788496B2 (https=)
KR (1) KR101852215B1 (https=)
CN (2) CN103180326B (https=)
AR (1) AR082618A1 (https=)
AU (1) AU2011290126B2 (https=)
BR (1) BR112013002250B1 (https=)
CA (1) CA2807460C (https=)
CL (1) CL2013000380A1 (https=)
CO (1) CO6680700A2 (https=)
CR (1) CR20130066A (https=)
CY (1) CY1123507T1 (https=)
DK (1) DK2603513T3 (https=)
DO (1) DOP2013000030A (https=)
EA (1) EA022078B1 (https=)
EC (1) ECSP13012478A (https=)
ES (1) ES2793723T3 (https=)
GE (1) GEP20156216B (https=)
HR (1) HRP20200844T1 (https=)
HU (1) HUE049460T2 (https=)
IL (1) IL224452A (https=)
LT (1) LT2603513T (https=)
MA (1) MA34509B1 (https=)
MX (1) MX349470B (https=)
MY (1) MY165908A (https=)
NZ (1) NZ607593A (https=)
PE (1) PE20131116A1 (https=)
PH (1) PH12013500247A1 (https=)
PL (1) PL2603513T3 (https=)
PT (1) PT2603513T (https=)
RS (1) RS60311B1 (https=)
SG (1) SG187656A1 (https=)
SI (1) SI2603513T1 (https=)
TW (1) TWI504604B (https=)
UA (1) UA111594C2 (https=)
UY (1) UY33551A (https=)
WO (1) WO2012020848A1 (https=)
ZA (1) ZA201301120B (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2603513T (lt) * 2010-08-10 2020-05-25 Takeda Pharmaceutical Company Limited Heterociklinis junginys ir jo panaudojimas kaip ampa receptoriaus teigiamo alosterinio moduliatoriaus
EP2694472B1 (en) * 2011-04-05 2020-03-11 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
JP6134654B2 (ja) * 2012-02-08 2017-05-24 武田薬品工業株式会社 複素環化合物およびその用途
EP3008167A4 (en) * 2013-06-13 2017-06-07 VeroScience LLC Compositions and methods for treating metabolic disorders
SG11201509186TA (en) 2013-06-27 2016-01-28 Pfizer Heteroaromatic compounds and their use as dopamine d1 ligands
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
CA2931961C (en) 2013-12-03 2023-10-31 Andrew Duncan Satterfield Pyrrolidinones as herbicides
SG11201610720VA (en) 2014-07-02 2017-01-27 Du Pont Piperidinone herbicides
CN107001260B (zh) 2014-12-08 2020-11-10 Fmc公司 3-氧基-3-(芳氨基)丙酸酯、其制备方法、以及其在制备吡咯烷酮中的用途
EP3280709B1 (en) 2015-04-10 2021-05-26 FMC Corporation Substituted cyclic amides as herbicides
BR112017020094B1 (pt) 2015-04-27 2022-01-11 Fmc Corporation Composto, composições herbicidas, mistura de herbicida e método para controlar o crescimento de vegetação indesejada
RS61688B1 (sr) 2015-04-29 2021-05-31 Janssen Pharmaceutica Nv Azabenzimidazoli i njihiova upotreba kao modulatori ampa receptora
WO2016176457A1 (en) * 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators
JP7000160B2 (ja) 2015-05-12 2022-01-19 エフ エム シー コーポレーション 除草剤としてのアリール置換二環式化合物
JP6869192B2 (ja) 2015-05-29 2021-05-12 エフ エム シー コーポレーションFmc Corporation 除草剤としての置換環状アミド
CN107709310B (zh) 2015-06-02 2021-09-24 Fmc公司 取代的环酰胺及其作为除草剂的用途
JP6937290B2 (ja) 2015-07-31 2021-09-22 エフ エム シー コーポレーションFmc Corporation 除草剤として有用な環状n−カルボキサミド化合物
CA2982825C (en) * 2015-08-06 2023-10-17 F. Hoffmann-La Roche Ag Processes for the preparation of galnac acid derivatives
US20170181292A1 (en) * 2015-12-16 2017-06-22 Rohm And Haas Electronic Materials Llc Method for forming organic coating on nickel surface
CN105669731B (zh) * 2016-01-10 2017-06-30 沧州普瑞东方科技有限公司 一种4‑(4‑烷基环己氧基)苯硼酸的合成方法
RU2019122791A (ru) 2016-12-21 2021-01-25 Фмк Корпорейшн Гербициды на основе нитрона
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用,药物组合物
MX2019010969A (es) 2017-03-21 2019-12-02 Fmc Corp Pirrolidinonas y proceso para prepararlas.
CN110740646B (zh) 2017-03-21 2022-05-10 Fmc公司 除草剂混合物、组合物和方法
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas
ES2970624T3 (es) 2017-10-06 2024-05-29 Takeda Pharmaceuticals Co Compuesto heterocíclico
EP3693360B1 (en) * 2017-10-06 2023-12-13 Takeda Pharmaceutical Company Limited Heterocyclic compounds
AU2020348675B2 (en) 2019-09-16 2025-11-20 Takeda Pharmaceutical Company Limited Azole-fused pyridazin-3(2H)-one derivatives
US20230338391A1 (en) * 2020-05-15 2023-10-26 Takeda Pharmaceutical Company Limited Treatment for depression
CN113943294A (zh) * 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途
WO2025224508A1 (en) 2024-04-22 2025-10-30 Takeda Pharmaceutical Company Limited Pharmaceutical composition for treating depressive disorders
WO2026050231A1 (en) 2024-08-27 2026-03-05 Neurocrine Biosciences, Inc. Method of treating a bipolar disorder

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0437742Y2 (https=) 1986-10-22 1992-09-04
JPH0285851A (ja) * 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH037742A (ja) 1989-06-05 1991-01-14 Toyo Tire & Rubber Co Ltd ラバーチエーン用ゴム組成物
JP2874960B2 (ja) * 1990-06-03 1999-03-24 コニカ株式会社 新規な染料を含有するハロゲン化銀写真感光材料
JPH04119890A (ja) * 1990-09-11 1992-04-21 Konica Corp ピラゾロチアジアジン系色素
JP3430375B2 (ja) * 1993-11-12 2003-07-28 コニカ株式会社 感熱転写材料及び該材料に好適な色素
DE19704923A1 (de) 1997-02-10 1998-08-13 Hoechst Schering Agrevo Gmbh Klebstoffhaltige Schädlingsbekämpfungsmittel
EP1229786A1 (en) 1999-11-04 2002-08-14 Colorado State University Method and device for attracting insects
FR2801587B1 (fr) 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2005508352A (ja) * 2001-10-10 2005-03-31 ニューロサーチ、アクティーゼルスカブ 新規ベンゾチアジン誘導体、その製造方法及びその使用方法
FR2833955B1 (fr) * 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) 2003-05-05 2005-07-08 Servier Lab Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2655376A1 (en) 2006-06-23 2007-12-27 Nufarm Australia Limited Phenoxy alkanoate herbicidal composition and method of preparation and use
US8097652B2 (en) 2006-12-11 2012-01-17 Eli Lilly And Company AMPA receptor potentiators
US20080167374A1 (en) 2007-01-09 2008-07-10 Loveland Products, Inc. Pesticide composition and method of use
US8487099B2 (en) * 2007-11-05 2013-07-16 Merck Sharp & Dohme Corp. Gamma secretase modulators
CA2709784A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
WO2009119088A1 (ja) 2008-03-25 2009-10-01 武田薬品工業株式会社 複素環化合物
JP2009248543A (ja) * 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法
TW201012803A (en) 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
EP2356115A1 (en) * 2008-11-06 2011-08-17 Schering Corporation Gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
FR2943342B1 (fr) 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010140339A1 (ja) 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
EP2455380A4 (en) 2009-07-13 2012-11-28 Takeda Pharmaceutical HETEROCYCLIC COMPOUND AND USE THEREOF
WO2011036885A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
LT2603513T (lt) * 2010-08-10 2020-05-25 Takeda Pharmaceutical Company Limited Heterociklinis junginys ir jo panaudojimas kaip ampa receptoriaus teigiamo alosterinio moduliatoriaus

Also Published As

Publication number Publication date
MA34509B1 (fr) 2013-09-02
US8916551B2 (en) 2014-12-23
CN104926837A (zh) 2015-09-23
CA2807460A1 (en) 2012-02-16
RS60311B1 (sr) 2020-07-31
CR20130066A (es) 2013-05-03
JP2016006080A (ja) 2016-01-14
GEP20156216B (en) 2015-01-12
CN103180326A (zh) 2013-06-26
UY33551A (es) 2012-03-30
MX349470B (es) 2017-07-31
US9150591B2 (en) 2015-10-06
CL2013000380A1 (es) 2013-05-31
US20240360156A1 (en) 2024-10-31
ES2793723T3 (es) 2020-11-16
KR20130138738A (ko) 2013-12-19
NZ607593A (en) 2015-01-30
JP5788496B2 (ja) 2015-09-30
PT2603513T (pt) 2020-06-08
MX2013001614A (es) 2013-07-05
US8778934B2 (en) 2014-07-15
SI2603513T1 (sl) 2020-07-31
UA111594C2 (uk) 2016-05-25
DOP2013000030A (es) 2013-03-15
US20140080817A1 (en) 2014-03-20
TW201217386A (en) 2012-05-01
ZA201301120B (en) 2014-04-30
AR082618A1 (es) 2012-12-19
CN103180326B (zh) 2015-06-10
AU2011290126A1 (en) 2013-03-07
JP6113789B2 (ja) 2017-04-12
AU2011290126B2 (en) 2016-01-07
CA2807460C (en) 2018-09-18
PH12013500247A1 (en) 2013-03-11
DK2603513T3 (da) 2020-06-15
WO2012020848A8 (en) 2012-09-27
US20180162875A1 (en) 2018-06-14
US11279713B2 (en) 2022-03-22
US10654874B2 (en) 2020-05-19
ECSP13012478A (es) 2013-04-30
MY165908A (en) 2018-05-18
EA201390222A1 (ru) 2013-08-30
LT2603513T (lt) 2020-05-25
SG187656A1 (en) 2013-03-28
EP2603513B1 (en) 2020-03-11
JP2013535408A (ja) 2013-09-12
CO6680700A2 (es) 2013-05-31
US8575154B2 (en) 2013-11-05
US20130190291A1 (en) 2013-07-25
US20190263832A1 (en) 2019-08-29
PL2603513T3 (pl) 2020-07-27
US20150073137A1 (en) 2015-03-12
US20120077799A1 (en) 2012-03-29
US20200317692A1 (en) 2020-10-08
BR112013002250A2 (pt) 2016-05-24
US20170022222A1 (en) 2017-01-26
US9499568B2 (en) 2016-11-22
US9884875B2 (en) 2018-02-06
CY1123507T1 (el) 2022-03-24
US20130184266A1 (en) 2013-07-18
PE20131116A1 (es) 2013-10-24
EA022078B1 (ru) 2015-10-30
WO2012020848A1 (en) 2012-02-16
HRP20200844T1 (hr) 2020-08-21
TWI504604B (zh) 2015-10-21
IL224452A (en) 2017-11-30
BR112013002250B1 (pt) 2020-10-27
US20150353578A1 (en) 2015-12-10
KR101852215B1 (ko) 2018-04-25
EP2603513A1 (en) 2013-06-19

Similar Documents

Publication Publication Date Title
HUE049460T2 (hu) Heterociklusos vegyület és annak alkalmazása ampa receptor pozitív allosztérikus modulátorként
IL246600B (en) Heterocyclic compounds and their use
EP2637669A4 (en) Heterocyclic compounds and their use
IL222288A0 (en) Heterocyclic compounds and their uses
IL225770A0 (en) Heterocyclic compounds
IL221442A0 (en) Heterocyclic compound
ZA201300950B (en) Heterocyclic compound
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
LT2594567T (lt) Heterocikliniai alkinilbenzeno junginiai ir jų medicininės kompozicijos bei panaudojimas
ZA201401434B (en) Heterocyclic compounds and uses thereof
PL2521450T3 (pl) Grzybobójcze związki heterocykliczne
IL230536A0 (en) Heterocyclic compounds and their uses
EP2678016A4 (en) HETEROCYCLIC COMPOUNDS AND USES THEREOF
IL231783A0 (en) History of ethinyl as allosteric modulators of 5mglur
ZA201306586B (en) Thynyl derivatives as positive allosteric modulators of the mglur5
IL223721A0 (en) Heterocyclic compounds, their preparation and their therapeutic application
ZA201300157B (en) Fused heterocyclic derivatives as s1p modulators
EP2782571A4 (en) HETEROCYCLIC COMPOUNDS AND USES THEREOF
PL2769720T3 (pl) Heterocykliczne allosteryczne modulatory gsk-3
GB2477949B (en) Powering of devices
GB201009514D0 (en) Novel heterocyclic compounds
GB201021416D0 (en) Novel heterocyclic compounds
AU331233S (en) Powder applicator